1. Home
  2. MOLN vs VLN Comparison

MOLN vs VLN Comparison

Compare MOLN & VLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • VLN
  • Stock Information
  • Founded
  • MOLN 2004
  • VLN 2006
  • Country
  • MOLN Switzerland
  • VLN Israel
  • Employees
  • MOLN N/A
  • VLN N/A
  • Industry
  • MOLN
  • VLN Semiconductors
  • Sector
  • MOLN
  • VLN Technology
  • Exchange
  • MOLN Nasdaq
  • VLN Nasdaq
  • Market Cap
  • MOLN 214.4M
  • VLN 208.5M
  • IPO Year
  • MOLN 2021
  • VLN N/A
  • Fundamental
  • Price
  • MOLN $5.31
  • VLN $1.93
  • Analyst Decision
  • MOLN
  • VLN Strong Buy
  • Analyst Count
  • MOLN 0
  • VLN 1
  • Target Price
  • MOLN N/A
  • VLN $4.00
  • AVG Volume (30 Days)
  • MOLN 26.6K
  • VLN 710.7K
  • Earning Date
  • MOLN 08-26-2024
  • VLN 11-06-2024
  • Dividend Yield
  • MOLN N/A
  • VLN N/A
  • EPS Growth
  • MOLN N/A
  • VLN N/A
  • EPS
  • MOLN N/A
  • VLN N/A
  • Revenue
  • MOLN $7,105,397.00
  • VLN $63,134,000.00
  • Revenue This Year
  • MOLN N/A
  • VLN N/A
  • Revenue Next Year
  • MOLN $29.41
  • VLN $28.20
  • P/E Ratio
  • MOLN N/A
  • VLN N/A
  • Revenue Growth
  • MOLN N/A
  • VLN N/A
  • 52 Week Low
  • MOLN $3.32
  • VLN $1.67
  • 52 Week High
  • MOLN $12.70
  • VLN $3.39
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 43.84
  • VLN 47.34
  • Support Level
  • MOLN $5.26
  • VLN $1.99
  • Resistance Level
  • MOLN $5.65
  • VLN $2.29
  • Average True Range (ATR)
  • MOLN 0.20
  • VLN 0.17
  • MACD
  • MOLN -0.04
  • VLN -0.01
  • Stochastic Oscillator
  • MOLN 6.85
  • VLN 23.21

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About VLN Valens Semiconductor Ltd.

Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Audio-Video, which includes the company's HDBaseT solutions for the Audio-Video market deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.

Share on Social Networks: